Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¸»±â ½ÅºÎÀü ȯÀÚÀÇ À§, ½ÊÀÌÁöÀå Á¡¸· º´º¯¿¡¼­ÀÇ Helicobacter pyloriÀÇ ¿ªÇÒ Role of Helicobacter pylori in Gastro-duodenl Mucosal Lesions in Patients with End-stage Renal Disease

´ëÇѽÅÀåÇÐȸÁö 1997³â 16±Ç 3È£ p.531 ~ 536
¼Ò¼Ó »ó¼¼Á¤º¸
Á¶±ºÁ¦/Goon Jae Cho À̼öºÀ/À¯¿µÀÏ/¹Ú¼º¹Î/¼ºÀº¿µ/°ûÀÓ¼ö/³ªÇÏ¿¬/Soo Bong Lee/Young Il Lee/Sung Min Park/Eun Young Seong/Ihm Soo Kwak/Ha Yeon Rha

Abstract

¿ä¾à
Helicobacter pylori(Hp)´Â ¼ÒÈ­¼º ±Ë¾ç, ¸¸¼º È°µ¿¼º À§¿° ±× ¿Ü ¿©·¯ »óºÎ À§Àå°ü Á¡¸·
º´º¯ÀÇ ¿øÀÎÀ¸·Î Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â °ÍÀ¸·Î »ý°¢µÇ°í ÀÖ´Ù. »óºÎ À§Àå°ü º´º¯Àº ¸»±â ½ÅºÎ
Àü ȯÀÚÀÇ °¡Àå ÈçÇÑ ÇÕº´Áõ ÁßÀÇ ÇϳªÀÌÁö¸¸ Hp °¨¿°À²°ú »óºÎ À§Àå°ü¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡
°üÇÑ ¿¬±¸´Â ¸¹Áö ¾Ê´Ù.
Åõ¼® ÁßÀÎ ¸»±â ½ÅºÎÀü ȯÀÚ¿¡¼­ Hp °¨¿°À²À» Æò°¡Çϱâ À§ÇØ 17¸íÀÇ »óºÎ À§Àå°ü Áõ¼¼°¡
ÀÖ´Â ¸»±â ½ÅºÎÀü ȯÀÚ¸¦ ´ë»óÀ¸·Î ½ÅÁúȯÀÌ ¾ø´Â 36¸íÀÇ È¯ÀÚ¸¦ ´ëÁ¶±ºÀ¸·Î ÇÏ¿© ³»½Ã°æ
°Ë»ç·Î À§Á¡¸·°ú À§¾×À» äÃëÇÏ¿© Hp È®ÀÎÀº rapid urease test(CLO test)·Î ÇÏ¿´´Ù.
Hp´Â Åõ¼® ȯÀÚ±º¿¡¼­´Â 35.3%¿¡¼­ °üÂûµÇ°í ´ëÁ¶°ü¿¡¼­´Â 77.8%·Î Åõ¼®±º¿¡¼­ ÀǹÌÀÖ
°Ô ³·Àº ºóµµ¿´À¸¸ç Hp ¾ç¼º ȯÀÚÀÇ À§½ÊÀÌÁöÀå º´º¯Àº ¹Ì¸¸¼º À§¿°, À§Ã༺ À§¿° ¹× Ç¥Àç
¼º À§¿°À̾ú´Ù. Åõ¼® ȯÀÚÀÇ À§¾× Áß ¾Ï¸ð´Ï¾ÆÄ¡´Â Hp ¾ç¼º±º¿¡¼­ Hp À½¼º±º¿¡ ºñÇØ ³ôÀº
Ä¡¸¦ º¸¿´´Ù(461.5¡¾211.2 vs. 244.4¡¾168.1¥ìg/mL, p<0.05).
°á·ÐÀûÀ¸·Î Åõ¼® ÁßÀÎ ¸»±â ½ÅºÎÀü ȯÀÚ´Â Á¤»ó ½Å±â´ÉÀ» Áö´Ñ À§Àå°ü ÁúȯÀÚ¿¡ ºñÇØ Hp
°¨¿°À²Àº ³·Àº ºóµµ¸¦ º¸ÀÌ°í Hp°¡ ¸»±â ½ÅºÎÀü ȯÀÚÀÇ »óºÎ À§Àå°ü º´º¯¿¡ ¹ÌÄ¡´Â ¿µÇâÀº
Á¤»ó ½Å±â´ÉÀÇ °æ¿ì¿¡ ºñÇØ ºñ±³Àû ³·Àº °æÇâÀÌ ÀÖÀ¸¸ç, ¸»±â ½ÅºÎÀü ȯÀÚÀÇ À§Àå°ü º´º¯ÀÇ
¿øÀÎ ±âÀüÀ¸·Î´Â Hp¿Í ÇÔ²² ½ÅºÎÀü ȯÀÚ¿¡¼­ »ç¿ëµÇ¾îÁö´Â ¿©·¯ ¾àÁ¦ µîÀÇ ¿©·¯ ¿øÀεéÀÌ
º¹ÇÕÀûÀ¸·Î °ü¿©ÇÒ °¡´É¼ºÀÌ ³ôÀº °ÍÀ¸·Î »ý°¢µÈ´Ù.
#ÃÊ·Ï#
Helocobacter pylori(Hp) is thought to play an important role in the pathogenesis of
active gastritis and other upper gastrointestinal mucosal lesions.
Although upper gastrointestinal mucosal lesion have been one of the most common
complication in patients with chronic renal failure. A few reports are available regarding
the prevalence of H. pylori and its influence on the upper gastrointestinal tract.
The objective of our study was to evaluate the prevalence of Hp in end-stage renal
failure who were undergoing dialysis.
The study population consisted of seventeen patients with upper gastrointestinal tract
symptoms. Thirty-six patients without any known kidney disease were used control.
Gastric mucosa and gastric juice were obtained endoscopically. Rapid urease test(CLO
test) were used for the determination of Hp.
Hp was observed in 35.3% of the dialysis group and 77.8% of the control.
Gastroduodenal lesion in Hp positive dialysis patients included erosive gastritis, atrophic
gastritis and superficial gastritis. In the dialysis group, ammonia concentration in gastric
juice were higher in patients with Hp than in those without HP (461.5¡¾211.1 vs. 244.4¡¾
168.1 ¥ìg/mL, p<0.05). Patients with end-stage renal failure who were undergoing
dialysis were shown to have a low prevalence of Hp colonization.
In the end-stage renal failure, Hp is associated with peptic ulcer and chronic active
gastritis but its influence on the upper gastro- intestinal tract is milder than in those of
normal renal function. Several factor including Hp may play a role in the pathogenesis
of gastointestinal mucosal lesion.

Å°¿öµå

Helicobacter pylori; Upper gastrointestinal mucosal lesion; End-stage renal failure; Dialysis;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS